Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Keurig Dr Pepper Inc ha un obiettivo di prezzo di consenso pari a $35.83, stabilito in base alle ultime valutazioni degli analisti di 23. Le ultime 3 valutazioni degli analisti sono state rilasciate da Barclays, Wells Fargo y JP Morgan il octubre 28, 2025, octubre 28, 2025 y octubre 20, 2025. Con un obiettivo di prezzo medio di $33.67 tra le Barclays, Wells Fargo y JP Morgan, c'è un implicito 22.11% upside per Keurig Dr Pepper Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Barclays
Wells Fargo
JP Morgan
B of A Securities
Goldman Sachs
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Keurig Dr Pepper
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/28/2025 | 8.81% | Barclays | $26 → $30 | Maintains | Equal-Weight | |||
10/28/2025 | 26.95% | Wells Fargo | $33 → $35 | Maintains | Overweight | |||
10/20/2025 | 30.58% | JP Morgan | $39 → $36 | Maintains | Overweight | |||
10/08/2025 | 19.7% | B of A Securities | $41 → $33 | Maintains | Buy | |||
10/02/2025 | 5.19% | Goldman Sachs | $34 → $29 | Maintains | Neutral | |||
09/25/2025 | 19.7% | Wells Fargo | $40 → $33 | Maintains | Overweight | |||
09/24/2025 | -5.69% | Barclays | $39 → $26 | Downgrade | Overweight → Equal-Weight | |||
09/22/2025 | -12.95% | BNP Paribas | → $24 | Downgrade | Neutral → Underperform | |||
09/17/2025 | 26.95% | Piper Sandler | $40 → $35 | Maintains | Overweight | |||
09/16/2025 | 34.2% | Citigroup | $41 → $37 | Maintains | Buy | |||
08/27/2025 | 26.95% | UBS | $40 → $35 | Maintains | Buy | |||
08/26/2025 | 37.83% | Deutsche Bank | $40 → $38 | Maintains | Buy | |||
08/26/2025 | 8.81% | HSBC | $42 → $30 | Downgrade | Buy → Hold | |||
07/28/2025 | 41.46% | Barclays | $37 → $39 | Maintains | Overweight | |||
07/17/2025 | 37.83% | JP Morgan | $39 → $38 | Maintains | Overweight | |||
07/17/2025 | 45.09% | UBS | $42 → $40 | Maintains | Buy | |||
06/27/2025 | 34.2% | Barclays | $38 → $37 | Maintains | Overweight | |||
04/28/2025 | 37.83% | Barclays | $37 → $38 | Maintains | Overweight | |||
04/25/2025 | 52.34% | HSBC | $36 → $42 | Upgrade | Hold → Buy | |||
04/22/2025 | 52.34% | RBC Capital | $42 → $42 | Reiterates | Outperform → Outperform | |||
04/17/2025 | 52.34% | UBS | $40 → $42 | Maintains | Buy | |||
04/16/2025 | 45.09% | Argus Research | → $40 | Initiates | → Buy | |||
04/09/2025 | 45.09% | Piper Sandler | $35 → $40 | Upgrade | Neutral → Overweight | |||
04/01/2025 | 45.09% | Morgan Stanley | $38 → $40 | Upgrade | Equal-Weight → Overweight | |||
02/27/2025 | 41.46% | Barclays | $36 → $39 | Maintains | Overweight | |||
02/26/2025 | 45.09% | JP Morgan | $37 → $40 | Maintains | Overweight | |||
02/26/2025 | 37.83% | Morgan Stanley | $36 → $38 | Maintains | Equal-Weight | |||
01/17/2025 | 30.58% | Barclays | $39 → $36 | Maintains | Overweight | |||
01/16/2025 | 34.2% | UBS | $42 → $37 | Maintains | Buy | |||
01/08/2025 | 30.58% | TD Cowen | $39 → $36 | Maintains | Hold | |||
01/07/2025 | 45.09% | Wells Fargo | $42 → $40 | Maintains | Overweight | |||
01/07/2025 | 26.95% | Piper Sandler | → $35 | Initiates | → Neutral | |||
12/12/2024 | 41.46% | Deutsche Bank | $37 → $39 | Upgrade | Hold → Buy | |||
10/28/2024 | 41.46% | Barclays | $41 → $39 | Maintains | Overweight | |||
10/25/2024 | 52.34% | UBS | $43 → $42 | Maintains | Buy | |||
10/25/2024 | 45.09% | Citigroup | $43 → $40 | Maintains | Buy | |||
10/25/2024 | 52.34% | RBC Capital | $41 → $42 | Maintains | Outperform | |||
10/25/2024 | 48.71% | Jefferies | $42 → $41 | Maintains | Buy | |||
10/25/2024 | 45.09% | JP Morgan | $41 → $40 | Maintains | Overweight | |||
10/25/2024 | 52.34% | Wells Fargo | $43 → $42 | Maintains | Overweight | |||
10/16/2024 | 48.71% | JP Morgan | $38 → $41 | Maintains | Overweight | |||
10/11/2024 | 48.71% | Barclays | $37 → $41 | Maintains | Overweight | |||
10/07/2024 | 55.97% | UBS | $39 → $43 | Maintains | Buy | |||
09/26/2024 | 45.09% | TD Cowen | $35 → $40 | Maintains | Hold | |||
09/23/2024 | 34.2% | Deutsche Bank | $36 → $37 | Maintains | Hold | |||
09/23/2024 | 55.97% | Citigroup | $36 → $43 | Upgrade | Neutral → Buy | |||
07/26/2024 | 48.71% | RBC Capital | $41 → $41 | Reiterates | Outperform → Outperform | |||
07/19/2024 | 34.2% | Barclays | $38 → $37 | Maintains | Overweight | |||
07/12/2024 | 41.46% | UBS | $40 → $39 | Maintains | Buy | |||
07/10/2024 | 30.58% | JP Morgan | $37 → $36 | Maintains | Overweight | |||
06/24/2024 | 30.58% | Exane BNP Paribas | → $36 | Initiates | → Neutral | |||
06/17/2024 | 23.32% | Truist Securities | $27 → $34 | Upgrade | Sell → Hold | |||
06/10/2024 | 45.09% | UBS | $39 → $40 | Maintains | Buy | |||
06/05/2024 | 48.71% | Wells Fargo | $39 → $41 | Maintains | Overweight | |||
04/29/2024 | 37.83% | Barclays | $36 → $38 | Maintains | Overweight | |||
04/26/2024 | 26.95% | TD Cowen | $32 → $35 | Maintains | Hold | |||
04/12/2024 | 30.58% | Barclays | $32 → $36 | Maintains | Overweight | |||
03/27/2024 | 26.95% | Jefferies | $37 → $35 | Maintains | Buy | |||
03/12/2024 | 16.07% | Barclays | $34 → $32 | Maintains | Overweight | |||
02/26/2024 | 23.32% | Morgan Stanley | $37 → $34 | Maintains | Equal-Weight | |||
02/26/2024 | 26.95% | Wedbush | $37 → $35 | Maintains | Outperform | |||
02/23/2024 | 48.71% | RBC Capital | $42 → $41 | Maintains | Outperform | |||
02/23/2024 | 23.32% | Barclays | $37 → $34 | Maintains | Overweight | |||
01/16/2024 | 34.2% | Barclays | $36 → $37 | Maintains | Overweight | |||
01/03/2024 | 34.2% | Morgan Stanley | → $37 | Downgrade | Overweight → Equal-Weight | |||
12/22/2023 | 34.2% | HSBC | → $37 | Initiates | → Hold | |||
11/13/2023 | 41.46% | Jefferies | → $39 | Initiates | → Buy | |||
10/30/2023 | 30.58% | Barclays | $34 → $36 | Maintains | Overweight | |||
10/27/2023 | 34.2% | Morgan Stanley | $39 → $37 | Maintains | Overweight | |||
10/12/2023 | 23.32% | Barclays | $40 → $34 | Maintains | Overweight | |||
10/12/2023 | 34.2% | Bernstein | $40 → $37 | Maintains | Outperform | |||
10/11/2023 | 19.7% | Citigroup | $37 → $33 | Maintains | Neutral | |||
08/16/2023 | 52.34% | UBS | $37 → $42 | Upgrade | Neutral → Buy | |||
07/28/2023 | 45.09% | Barclays | $37 → $40 | Maintains | Overweight | |||
07/11/2023 | 34.2% | Wedbush | $40 → $37 | Maintains | Outperform | |||
07/11/2023 | 26.95% | Citigroup | $37 → $35 | Maintains | Neutral | |||
07/06/2023 | 34.2% | Morgan Stanley | → $37 | Upgrade | Equal-Weight → Overweight | |||
05/01/2023 | 52.34% | RBC Capital | → $42 | Reiterates | → Outperform | |||
05/01/2023 | 34.2% | Barclays | $42 → $37 | Maintains | Overweight | |||
04/28/2023 | 45.09% | Wedbush | $43 → $40 | Maintains | Outperform | |||
04/28/2023 | 34.2% | Barclays | $42 → $37 | Maintains | Overweight | |||
04/18/2023 | 48.71% | JP Morgan | $40 → $41 | Maintains | Overweight | |||
04/14/2023 | 52.34% | Barclays | $40 → $42 | Maintains | Overweight | |||
03/20/2023 | 30.58% | Deutsche Bank | $38 → $36 | Maintains | Hold | |||
02/27/2023 | 45.09% | Barclays | $45 → $40 | Maintains | Overweight | |||
02/17/2023 | 34.2% | Citigroup | → $37 | Initiates | → Neutral | |||
01/26/2023 | 48.71% | JP Morgan | $40 → $41 | Maintains | Overweight | |||
01/03/2023 | 45.09% | Wells Fargo | $42 → $40 | Maintains | Overweight | |||
12/06/2022 | 41.46% | Deutsche Bank | $38 → $39 | Maintains | Hold | |||
10/31/2022 | 63.22% | Barclays | $41 → $45 | Maintains | Overweight | |||
10/31/2022 | 8.81% | Truist Securities | → $30 | Downgrade | Hold → Sell |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Keurig Dr Pepper (KDP)?
El último precio objetivo de Keurig Dr Pepper (NASDAQ:KDP) fue comunicado por Barclays el octubre 28, 2025. La firma de analistas fijó un precio objetivo para $30.00 que espera KDP a rise dentro de 12 meses (un posible 8.81% upside). 33 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Keurig Dr Pepper (KDP)?
La última calificación de analistas para Keurig Dr Pepper (NASDAQ:KDP) fue proporcionada por Barclays, y Keurig Dr Pepper mantuvo su equal-weight calificación.
¿Cuándo se produjo la última revisión al alza de Keurig Dr Pepper (KDP)?
La última revisión al alza de Keurig Dr Pepper Inc se produjo en abril 25, 2025, cuando HSBC elevó su precio objetivo a $42. HSBC anteriormente tenía a hold para Keurig Dr Pepper Inc.
¿Cuándo fue la última revisión a la baja de Keurig Dr Pepper (KDP)?
La última revisión a la baja de Keurig Dr Pepper Inc se produjo en septiembre 24, 2025, cuando Barclays cambió su precio objetivo de $39 a $26 para Keurig Dr Pepper Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Keurig Dr Pepper (KDP)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Keurig Dr Pepper, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Keurig Dr Pepper se registró el octubre 28, 2025, por lo que la próxima calificación estará disponible en torno al octubre 28, 2026.
¿Es correcta la calificación de los analistas sobre Keurig Dr Pepper (KDP)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Keurig Dr Pepper (KDP) fue un mantuvo con un precio objetivo de $26.00 a $30.00. El precio actual al que cotiza Keurig Dr Pepper (KDP) es de $27.57, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.